Welsh
English
Afrikaans
Albanian
Arabic
Armenian
Azerbaijani
Basque
Belarusian
Bulgarian
Catalan
Chinese (Simplified)
Chinese (Traditional)
Croatian
Czech
Danish
Dutch
Estonian
Filipino
Finnish
French
Galician
Georgian
German
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Malay
Maltese
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Thai
Turkish
Ukrainian
Urdu
Vietnamese
Welsh
Yiddish
Uchafbwyntiau O 15eg Cyngres Flynyddol EAHAD
Dadansoddiad Terfynol O Gam 3 Hanfodol Treial Therapi Genynnau HOPE-B: Effeithlonrwydd a Diogelwch Cyflwr Cymedrol Sefydlog Etranacogene Dezaparvovec mewn Oedolion â Hemoffilia B Difrifol neu Gymedrol Ddifrifol
Wolfgang Miesbach1; Frank WGleebeek2; Michael Recht3; Nigel S. Allwedd4; Susan Lattimore3; Giancarlo Castaman5; Michael Coppens6; David Cooper7; Sergio Slawka7; Stephanie Verweij7; Robert Gut7; Ricardo Dolmetsch7; Yanyan Li8; Paul E. Monahan8; Steven W. Pib9
Ymchwilwyr HOPE-B1; Ysbyty Athrofaol Frankfurt, Frankfurt, yr Almaen2; Erasmus MC, Canolfan Feddygol y Brifysgol Rotterdam, yr Iseldiroedd3; Prifysgol Iechyd a Gwyddoniaeth Oregon, Portland, NEU, Unol Daleithiau America4; Prifysgol Gogledd Carolina, Chapel Hill, NC, Unol Daleithiau America5; Canolfan ar gyfer Anhwylderau Gwaedu a Cheulo, Ysbyty Prifysgol Careggi, Fflorens, yr Eidal6; Canolfannau Meddygol Prifysgol Amsterdam, Prifysgol Amsterdam, Amsterdam, yr Iseldiroedd7; uniQureBV, Amsterdam, yr Iseldiroedd/uniQure Inc. Lexington, MA, UDA8; CSL Behring, Brenin Prwsia, PA, Unol Daleithiau America9; Prifysgol Michigan, Ann Arbor, MI, Unol Daleithiau America
CYNNWYS CYSYLLTIEDIG
